- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 491/14
Total number of patents in this class: 202
10-year publication summary
|
19
|
12
|
9
|
13
|
3
|
19
|
13
|
15
|
17
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5668 |
10 |
| Genentech, Inc. | 4076 |
5 |
| Amgen Inc. | 4357 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2648 |
5 |
| Gilead Sciences, Inc. | 2189 |
5 |
| F. Hoffmann-La Roche AG | 7837 |
4 |
| Jubilant Biosys Limited | 19 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2973 |
4 |
| Fundacion Del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III (f.s.p. Cnio) | 63 |
4 |
| Sudo Biosciences Limited | 29 |
4 |
| Novartis AG | 10327 |
3 |
| LG Chem, Ltd. | 17846 |
3 |
| Samsung SDI Co., Ltd. | 9976 |
3 |
| Incyte Corporation | 1060 |
3 |
| Rigel Pharmaceuticals, Inc. | 509 |
3 |
| Rutgers, The State University of New Jersey | 1956 |
3 |
| UDC Ireland Limited | 514 |
3 |
| Veiled Therapeutics, LLC | 10 |
3 |
| Convalife (Shanghai) Co., Ltd. | 20 |
3 |
| Samsung Electronics Co., Ltd. | 154406 |
2 |
| Other owners | 123 |